Filing Details

Accession Number:
0000904454-11-000679
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-12-22 17:51:53
Reporting Period:
2011-12-22
Filing Date:
2011-12-22
Accepted Time:
2011-12-22 17:51:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1382911 Orexigen Therapeutics Inc. OREX Pharmaceutical Preparations (2834) 651178822
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1372932 Dp Vii Associates Lp C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-12-22 7,882 $1.45 50,643 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2011-12-22 7,882 $14.49 78,820 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,882 2011-12-22 2021-12-22 No 4 P Direct
Footnotes
  1. The Common Stock and Warrants were sold as units at a purchase price of $15.94 per unit, each unit consisting of one share of Common Stock and one Warrant to purchase ten shares of Common Stock.